Departments & Organizations
Dr. Wang obtained his BA from Harvard University and his MD, PhD degrees in 2011 from University of Texas Southwestern with additional training done at the University of Paris. As a part of his MD/PhD training in the laboratories of Drs. Edward Wakeland and Chandra Mohan, he identified a key role for the CXCR4/SDF-1 axis in end-organ targeting, an important insight in the pathogenesis of SLE. He did his internal medicine internship and residency training at Yale and joined the ABIM Short Track Pathway into Rheumatology fellowship.
Dr. Wang joined the laboratory of Dr. Ruslan Medzhitov in July 2014 for his postdoctoral training. There, his focus shifted to understanding how inflammation and metabolism are coordinated on an organismal level. His work in Dr. Medzhitov's laboratory led to the discovery that different inflammatory states are coordinated with different metabolic programs. He is continuing work in this area at the bench as well as the bedside, including the organization of a clinical trial to test translatability of his work. He joined the faculty as Assistant Professor in Internal Medicine (Rheumatology) in August 2017. His lab focuses on inflammation and metabolism.
Education & Training
|MD/PhD||University of Paris V, Immunobiology (2011)|
|MD/PhD||University of Texas Southwestern Medical School, Immunobiology (2011)|
|AB||Harvard University, Biochemistry (2004)|
|ABIM Research Pathway Resident||Yale University School of Medicine/Yale New Haven Hospital|
|Board Certification||AB of Internal Medicine, Internal Medicine (2017)|